This early-phase trial tests whether adding dapansutrile (an anti-inflammatory pill) to pembrolizumab (an immunotherapy) can help people with advanced melanoma whose cancer no longer responds to PD-1 inhibitors. About 26 adults with unresectable stage III or IV melanoma will take…
Phase: PHASE1, PHASE2 • Sponsor: April Salama, M.D. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC